Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Editas Medicine Inc is a gene-editing company. It is engaged in treating patients with genetically defined diseases by correcting disease-causing genes. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR... Editas Medicine Inc is a gene-editing company. It is engaged in treating patients with genetically defined diseases by correcting disease-causing genes. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company's only operating segment is developing and commercializing genome editing technology. Mehr anzeigen
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.5501 | -28.5025906736 | 1.93 | 2.02 | 1.36 | 2750807 | 1.62096358 | CS |
| 4 | 0.1799 | 14.9916666667 | 1.2 | 3.2999 | 1.17 | 7725528 | 2.29250288 | CS |
| 12 | -0.0201 | -1.43571428571 | 1.4 | 3.2999 | 1.12 | 4192189 | 1.94106155 | CS |
| 26 | -2.4001 | -63.4947089947 | 3.78 | 4.12 | 1.12 | 3221395 | 2.2965969 | CS |
| 52 | -7.1801 | -83.8796728972 | 8.56 | 8.86 | 1.12 | 2545891 | 3.47982397 | CS |
| 156 | -13.6801 | -90.8373173971 | 15.06 | 21.595 | 1.12 | 2033887 | 7.6800079 | CS |
| 260 | -18.0501 | -92.8980957283 | 19.43 | 99.95 | 1.12 | 1860219 | 19.89645238 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
